SCHEMBL29831692

SCHEMBL29831692

COc1cccc2ncncc12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 5/20 0.47
CYP1A2 P05177 3/20 0.44
CYP3A4 P08684 3/20 0.44
HSD17B10 Q99714 2/20 0.44
ALDH1A1 P00352 2/20 0.44
TDP1 Q9NUW8 1/20 0.44
NQO2 P16083 1/20 0.42
LMNA P02545 2/20 0.41
CYP2D6 P10635 2/20 0.41
CYP2C19 P33261 2/20 0.41
ALOX15 P16050 1/20 0.41
KEAP1 Q14145 1/20 0.41
NFE2L2 Q16236 1/20 0.41
PDPK1 O15530 1/20 0.41
GRM5 P41594 2/20 0.40
KCNH2 Q12809 2/20 0.40
ABCG2 Q9UNQ0 2/20 0.40
CLK4 Q9HAZ1 2/20 0.40
MAP4K4 O95819 2/20 0.40
USP2 O75604 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL5736824 0.98 EGFR (0.46) EGFRCYP1A2CYP3A4HSD17B10ALDH1A1
Formic Acid SCHEMBL30699784 0.89 EGFR (0.41) EGFRCYP1A2CYP3A4HSD17B10ALDH1A1
SCHEMBL29832602 0.82 KDM1A (0.46) EGFRCYP1A2CYP3A4ALDH1A1LMNA
SCHEMBL5682821 0.81 MCHR1 (0.41) EGFRGRM5HTR1AHTR1DHTR1B
SCHEMBL27647885 0.76 HTR1A (0.44) EGFRHTR1AHTR1DHTR1B
SCHEMBL1770673 0.75 ALDH1A1 (0.35) EGFRCYP1A2CYP3A4HSD17B10ALDH1A1
1,2-Dimethoxybenzene SCHEMBL28232593 0.75 EGFR (0.69) EGFRCYP1A2CYP3A4HSD17B10ALDH1A1
SCHEMBL3820499 0.75 EGFR (0.47) EGFRCYP1A2CYP3A4ALDH1A1CYP2D6
SCHEMBL29096082 0.75 SYK (0.57) HSD17B10ALDH1A1LMNAGRM5KCNH2
SCHEMBL96953 0.75 SYK (0.57) HSD17B10ALDH1A1LMNAGRM5KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11407719-B2 Anti-inflammatory agents RESVERLOGIX CORP. (CA) 2022-08-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11407719-B2 Anti-inflammatory agents VCAM1, ICAM1, IL6 EGFR 3489/4885CYP1A2 3571/4885CYP3A4 3575/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.